We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-11.22%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$253M
AUM Growth
-$16M
Cap. Flow
+$286M
Cap. Flow %
113.05%
Top 10 Hldgs %
44%
Holding
60
New
10
Increased
18
Reduced
9
Closed
22

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$260M
2
TMO icon
Thermo Fisher Scientific
TMO
+$26M
3
NVO
Novo Nordisk
NVO
+$14.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$11.6M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$8.31M
2
SNY icon
Sanofi
SNY
+$7.53M
3
BSX icon
Boston Scientific
BSX
+$6.54M
4
AMGN icon
Amgen
AMGN
+$6.03M
5
THC icon
Tenet Healthcare
THC
+$5.67M

Sector Composition

Rank Sector Weight
1 Healthcare 98.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$133B
$4.43M 1.75%
25,000
-7,500
-23% -$1.72M
LLY icon
27
Eli Lilly
LLY
$1.09T
$4.39M 1.73%
60,000
+10,000
+20% +$1.37M
SEM
28
DELISTED
Select Medical
SEM
$4.16M 1.64%
+148,480
New +$1.76M
HRC
29
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$4.04M 1.6%
40,000
+20,100
+101% +$2.08M
CRL icon
30
Charles River Laboratories
CRL
$13.6B
$4.04M 1.59%
+15,000
New +$2.25M
BSX icon
31
Boston Scientific
BSX
$74.5B
$3.71M 1.47%
7,500
-167,500
-96% -$6.54M
TMO icon
32
Thermo Fisher Scientific
TMO
$223B
$3.59M 1.42%
100,000
+82,500
+471% +$26M
GRFS
33
Grifois
GRFS
$5.4B
$3.52M 1.39%
175,000
-100,000
-36% -$2.24M
ABBV icon
34
AbbVie
ABBV
$440B
$3.51M 1.38%
10,000
-40,000
-80% -$3.41M
BAX icon
35
Baxter International
BAX
$13.9B
$3.41M 1.34%
15,000
-55,000
-79% -$4.75M
ZBH icon
36
Zimmer Biomet
ZBH
$18.7B
$2.52M 1%
20,600
-15,450
-43% -$2.03M
THC icon
37
Tenet Healthcare
THC
$21.5B
$2.45M 0.97%
17,500
-197,500
-92% -$5.67M
STE icon
38
Steris
STE
$23.1B
$280K 0.11%
+5,823
New +$871K
ALC icon
39
Alcon
ALC
$35.6B
– –
-45,000
Closed -$2.55M
ALGN icon
40
Align Technology
ALGN
$12.4B
– –
-15,000
Closed -$4.19M
AMGN icon
41
Amgen
AMGN
$225B
– –
-25,000
Closed -$6.03M
AVTR icon
42
Avantor
AVTR
$9.42B
– –
-150,000
Closed -$2.72M
BIO icon
43
Bio-Rad Laboratories Class A
BIO
$9.68B
– –
-15,000
Closed -$5.55M
BLUE
44
DELISTED
bluebird bio
BLUE
– –
-1,544
Closed -$1.75M
BPMC
45
DELISTED
Blueprint Medicines
BPMC
– –
-18,520
Closed -$1.48M
CRSP icon
46
CRISPR Therapeutics
CRSP
$5.22B
– –
-25,000
Closed -$1.52M
DGX icon
47
Quest Diagnostics
DGX
$26.2B
– –
-27,500
Closed -$2.94M
ELV icon
48
Elevance Health
ELV
$86.6B
– –
-27,500
Closed -$8.31M
EW icon
49
Edwards Lifesciences
EW
$53.6B
– –
-45,000
Closed -$3.5M
ILMN icon
50
Illumina
ILMN
$29.1B
– –
-10,280
Closed -$3.32M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q1 2020 Portfolio in Review

As of Q1 2020, Sivik Global Healthcare held 60 positions worth $253M, down 5.9% from $269M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sivik Global Healthcare deployed $286M of net new capital in Q1 2020, opening 10 new positions and adding to 18 existing holdings. Its largest new stake was Novo Nordisk: 500,000 shares worth $8.16M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was Boston Scientific, an estimated $6.54M trimmed.

  • Sivik Global Healthcare's largest Q1 2020 buy was Novo Nordisk: 500,000 shares worth $8.16M.
  • Sivik Global Healthcare added most to Intuitive Surgical in Q1 2020, an estimated $260M increase.
  • Sivik Global Healthcare's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $6.54M.
  • Sivik Global Healthcare fully exited Elevance Health in Q1 2020, selling an estimated $8.31M.
  • Sivik Global Healthcare's ten largest holdings make up 44% of its $253M portfolio in Q1 2020.
  • Sivik Global Healthcare opened 10 new positions and closed 22 in Q1 2020.
  • Sivik Global Healthcare's portfolio value fell 5.9% quarter-over-quarter to $253M.

Based on Sivik Global Healthcare's 13F filing for Q1 2020, filed 15 May 2020.